Hepatitis B and its Relationship With Oxidative Stress

Authors Information
Article Notes and Dates
To Cite : Alavian S M, Showraki A. Hepatitis B and its Relationship With Oxidative Stress, Hepat Mon. 2016 ;16(9):e37973. doi: 10.5812/hepatmon.37973.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. Blumberg BS, Alter HJ, Visnich S. A "New" Antigen in Leukemia Sera. JAMA. 1965; 191: 541-6[PubMed]
  • 2. CDC . Viral hepatitis . 2013;
  • 3. Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis delta virus. 2005; : 1864-90
  • 4. Halegoua-De Marzio D, Hann HW. Then and now: the progress in hepatitis B treatment over the past 20 years. World J Gastroenterol. 2014; 20(2): 401-13[DOI][PubMed]
  • 5. McClune AC, Tong MJ. Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis. 2010; 14(3): 461-76[DOI][PubMed]
  • 6. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7): 2557-76[DOI][PubMed]
  • 7. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther. 2011; 34(10): 1145-58[DOI][PubMed]
  • 8. Santantonio TA, Fasano M. Chronic hepatitis B: Advances in treatment. World J Hepatol. 2014; 6(5): 284-92[DOI][PubMed]
  • 9. Gitler C, Danon A. Cellular implications of redox signaling. 2003;
  • 10. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med. 2008; 45(1): 1-17[DOI][PubMed]
  • 11. Thanan R, Oikawa S, Hiraku Y, Ohnishi S, Ma N, Pinlaor S, et al. Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer. Int J Molecul Sci. 2014; 16(1): 193-217
  • 12. Ames BN, Shigenaga MK. Oxidants are a major contributor to aging. Ann N Y Acad Sci. 1992; 663: 85-96[PubMed]
  • 13. Cai Z, Yan LJ. Protein Oxidative Modifications: Beneficial Roles in Disease and Health. J Biochem Pharmacol Res. 2013; 1(1): 15-26[PubMed]
  • 14. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003; 108(16): 1912-6[DOI][PubMed]
  • 15. Porter NA, Caldwell SE, Mills KA. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 1995; 30(4): 277-90[PubMed]
  • 16. Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012; 2012: 137289[DOI][PubMed]
  • 17. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005; 15(4): 316-28[DOI][PubMed]
  • 18. Fan YC, Wang K, Han LY, Li XH, Wang HM, Wang LY, et al. [Oxidative stress in patients with chronic hepatitis B before and after interferon alpha-2b treatment]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007; 21(1): 23-5[PubMed]
  • 19. Dikici I, Mehmetoglu I, Dikici N, Bitirgen M, Kurban S. Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-alpha treatment. Clin Biochem. 2005; 38(12): 1141-4[DOI][PubMed]
  • 20. Namiduru ES, Namiduru M, Tarakcioglu M, Tanriverdi M. Levels of malondialdehyde, myeloperoxidase and nitrotyrosine in patients with chronic viral hepatitis B and C. Adv Clin Exp Med. 2012; 21(1): 47-53[PubMed]
  • 21. Cai S, Wang K, Han LY, Fan YC, Ge J, Yu SX, et al. [Study of oxidative stress in chronic hepatitis B patients with elevated serum total bilirubin]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010; 24(2): 131-3[PubMed]
  • 22. Pak SG, Nikitin EV. [Status of the processes of free-radical oxidation and the antioxidation system in patients with a severe course of hepatitis B]. Klin Med (Mosk). 1991; 69(9): 54-7[PubMed]
  • 23. Sen V, Uluca U, Ece A, Kaplan I, Bozkurt F, Aktar F, et al. Serum prolidase activity and oxidant-antioxidant status in children with chronic hepatitis B virus infection. Ital J Pediatr. 2014; 40: 95[DOI][PubMed]
  • 24. Wang K, Wang B, Fan XP, Lin YJ, Shui WP. [Oxidative stress in patients with chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004; 18(2): 172-4[PubMed]
  • 25. Acar A, Gorenek L, Aydin A, Eyigun CP, Eken A, Sayal A, et al. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress]. Mikrobiyol Bul. 2009; 43(3): 411-23[PubMed]
  • 26. Boldyrev NA, Kozlov AV, Zmyzgova AV, Azizova OA, Roslyi IM, Musarov AL, et al. [Caused of intensified lipid peroxidation in the blood of patients with viral hepatitis B]. Biull Eksp Biol Med. 1990; 110(9): 297-8[PubMed]
  • 27. Fan XP, Wang K, Liu Y, Wang JF. Plasma α-Tocopherol is Negatively Correlated with Hepatocyte Apoptosis in Chronic Hepatitis B Patients. Internal Med. 2009; 48(18): 1585-93
  • 28. Mahdy KA, Abd-El-Shaheed A, Khadr ME, El-Shamy KA. Antioxidant status and lipid peroxidation activity in evaluating hepatocellular damage in children. East Mediterr Health J. 2009; 15(4): 842-52[PubMed]
  • 29. Tsai SM, Lin SK, Lee KT, Hsiao JK, Huang JC, Wu SH, et al. Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. Ann Clin Biochem. 2009; 46: 394-400[DOI][PubMed]
  • 30. Demirdag K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A, Kilic SS. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepatogastroenterology. 2003; 50(51): 766-70[PubMed]
  • 31. Zhao J, Fan YC, Sun FK, Zhao ZH, Wang LY, Hu LH, et al. Peripheral type I interferon receptor correlated with oxidative stress in chronic hepatitis B virus infection. J Interferon Cytokine Res. 2013; 33(8): 405-14[PubMed]
  • 32. Tasdelen Fisgin N, Aydin BK, Sarikaya H, Tanyel E, Esen S, Sunbul M, et al. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin Lab. 2012; 58(3-4): 273-80[PubMed]
  • 33. Karsen H, Binici I, Sunnetcioglu M, Baran AI, Ceylan MR, Selek S, et al. Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B. Afr Health Sci. 2012; 12(2): 114-8[DOI][PubMed]
  • 34. Shaban NZ, Salem HH, Elsadany MA, Ali BA, Hassona EM, AK F. Alterations in lipid peroxidation and antioxidants in patients' with different stages of hepatitis b virus infection in Egypt. Life Sci J. 2014;
  • 35. Lebensztejn DM, Chwiecko M, Semeniuk J, Kaczmarski M, Farbiszewski R. The role of free oxygen radicals in children with chronic viral hepatitis B. Rocz Akad Med Bialymst. 1995; 40(3): 667-72[PubMed]
  • 36. Ciragil P, Kurutaş EB, Kokoglu OF, Aral M. Oxidative stress in patients with chronic hepatitis B and C. Balkan Med J. 2011; 2011(3)
  • 37. Kokoglu OF, Ucmak H, Kurutaş EB, Kuzhan N, Toprak R, Cetinkaya A. Oxidative stress biomarkers in urine of patients with hepatitis B and C. Balkan Med J. 2012; 2012(1)
  • 38. Pal S, Bose M, Paul S. A comparative study of oxidative stress parameters in hepatitis b virus infection & alcoholic hepatitis. J Drug Delivery Therapeutic. 2013; 3(5): 94-8
  • 39. Guler SA, Tolun FI, Ucmak H, Haskaya G, Yavuz M, Yavuz M. Relationship between antioxidant capacity and oxidative stress in patients with chronic hepatitis B. Advance Laboratory Med Int. 2014; 4(1): 17-25
  • 40. Dede ,F, Kos M, Bukan N, Sener D, Demir M, Aydin O. The evaluation of oxidative stress parameters in chronic viral hepatitis/Kronik viral hepatitli hastalarda oksidatif stres parametrelerinin degerlendirilmesi. Istanbul Med J. 2011; 12(4): 175-81
  • 41. Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D. Oxidative stress in alcoholic and viral hepatitis. N Am J Med Sci. 2012; 4(9): 412-5[DOI][PubMed]
  • 42. Muntean M, Bondor C, Ţatulescu D, Ţigan S, Mureşan A. Identification and Quantification of Oxidative Stress Serologic Markers in Acute Viral Hepatitis. Applied Med Inform. 2011; 18(1): 3-8
  • 43. Kaya S, Sutcu R, Cetin ES, Yılmaz N, Arıkan S, Arıdogan BC. Relationship Between Viral Load and Lipid Peroxidation and Antioxidant Enzymes in Patients Infected with Hepatitis B Virus. Mikrobiyol Bul. 2006;
  • 44. Li Q,, Chen M, Wang LP. Relationship between serum Iron, Ferritin and lipid peroxidation injury in patients with chronic hepatitis B. Chinese J Clin Hepatol. 2008; 3
  • 45. Novitskiĭ G, Mel'nikova G, Podlevskiĭ A, Vasil'ev V. Lipid peroxidation and composition of the erythrocyte membranes in patients with viral hepatitis B. Likars' Ka Sprava/Ministerstvo Okhorony Zdorov'ia Ukrainy. 1992; (1): 79-81
  • 46. Guangqun Z. Relation between Serum Trace Elements and Products of Lipid Peroxidation in Patients with Hepatitis B: A Clinical Epidemiological Study. J Guangdong College Pharmacy. 1990; 1(9)
  • 47. Osman HG, Gabr OM, Lotfy S, Gabr S. Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian J Med Microbiol. 2007; 25(4): 323-9[PubMed]
  • 48. Duygu F, Karsen H, Aksoy N, Taskin A. Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis. Ann Lab Med. 2012; 32(2): 113-8[DOI][PubMed]
  • 49. Jasim RH. Evaluation of Oxidative-Antioxidative Balance in Serum of Patients With Non Acute Hepatitis Virus Type B2011. 2011;
  • 50. Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol. 2002; 97(10): 2634-9[DOI][PubMed]
  • 51. Severi T, Ying C, Vermeesch JR, Cassiman D, Cnops L, Verslype C, et al. Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol Cell Biochem. 2006; 290(1-2): 79-85[DOI][PubMed]
  • 52. Ishizaka N, Ishizaka Y, Takahashi E, Toda Ei E, Hashimoto H, Ohno M, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002; 105(9): 1028-30[PubMed]
  • 53. Abel S, De Kock M, van Schalkwyk DJ, Swanevelder S, Kew MC, Gelderblom WC. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins Leukot Essent Fatty Acids. 2009; 81(5-6): 391-9[DOI][PubMed]
  • 54. Dudnik LB, Viksna LM, Maiore A. [Lipid peroxidation and its connection with the change in composition and antioxidant properties of lipids in comatogenic forms of acute viral hepatitis B]. Vopr Med Khim. 2000; 46(6): 597-609[PubMed]
  • 55. Qi L, Zou ZQ, Wang LY, Gao S, Fan YC, Long B, et al. Methylation of the glutathione-S-transferase M3 gene promoter is associated with oxidative stress in acute-on-chronic hepatitis B liver failure. Tohoku J Exp Med. 2012; 228(1): 43-51[PubMed]
  • 56. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med. 2003; 9(4): 169-76[PubMed]
  • 57. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta. 2003; 329(1): 23-38
  • 58. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev. 2000; 32(3-4): 307-26[DOI][PubMed]
  • 59. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996; 271(5 Pt 1)-37[PubMed]
  • 60. Kettle AJ. Detection of 3-chlorotyrosine in proteins exposed to neutrophil oxidants. Methods Enzymol. 1999; 300: 111-20[PubMed]
  • 61. Meng LZ, Gao AW, Bian JF, Han LJ, Chen H. Study on Correlation between Oxidation-antioxidation and Chronic Hepatitis Viral B. Occupation Health. 2010; 23
  • 62. Garcia-Monzon C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol. 2000; 32(2): 331-8[PubMed]
  • 63. Popadiuk S, Liberek A, Korzon M, Renke J, Wozniak M. [Free radical reactions and activity of antioxidant barrier in children with chronic hepatitis B]. Med Wieku Rozwoj. 2004; 8(2 Pt 2): 395-402[PubMed]
  • 64. Poungpairoj P, Whongsiri P, Suwannasin S, Khlaiphuengsin A, Tangkijvanich P, Boonla C. Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells. Asian Pac J Cancer Prev. 2015; 16(13): 5343-8[PubMed]
  • 65. Cadet J, Wagner JR. Oxidatively generated base damage to cellular DNA by hydroxyl radical and one-electron oxidants: similarities and differences. Arch Biochem Biophys. 2014; 557: 47-54[DOI][PubMed]
  • 66. Olinski R, Rozalski R, Gackowski D, Foksinski M, Siomek A, Cooke MS. Urinary measurement of 8-OxodG, 8-OxoGua, and 5HMUra: a noninvasive assessment of oxidative damage to DNA. Antioxidants Redox Signal. 2006; 8: 1011-9
  • 67. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 1994; 54(12): 3171-2[PubMed]
  • 68. Piciocchi M, Cardin R, Cillo U, Vitale A, Cappon A, Mescoli C, et al. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. Transl Res. 2016; 168: 122-33[DOI][PubMed]
  • 69. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol. 2001; 35(5): 613-8[PubMed]
  • 70. Ishizakai M, Yoshida K, Nishimoto N, Saleh AM, Ishii C, Handa H, et al. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases]. Rinsho Byori. 2004; 52(9): 732-6[PubMed]
  • 71. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proceed National Academy Sci. 1994; 91(26): 12808-12
  • 72. Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, et al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat. 2008; 15(7): 498-507[DOI][PubMed]
  • 73. Bhargava A, Khan S, Panwar H, Pathak N, Punde RP, Varshney S, et al. Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes. Virus Res. 2010; 153(1): 143-50[DOI][PubMed]
  • 74. Wang K, Han L, Lu Q, Wang B, Li X, Wang H. Nitric oxide and nitric oxide synthase in patients with chronic hepatitis B. Zhonghua shi yan he lin chuang bing du xue za zhi= Zhonghua shiyan he linchuang bingduxue zazhi. Chinese J Experiment Clin Virol. 2005; 19(2): 142-5
  • 75. Nagoev BS, Abidov MT, Ivanova MR. LPO and free-radical oxidation parameters in patients with acute viral hepatitis. Bull Exp Biol Med. 2002; 134(6): 557-8[PubMed]
  • 76. Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biol. 2013; 1: 483-91[DOI][PubMed]
  • 77. Schindhelm RK, van der Zwan LP, Teerlink T, Scheffer PG. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin Chem. 2009; 55(8): 1462-70[DOI][PubMed]
  • 78. Bekheet I, Madkour M, Ghaffar NA, Nosseir M, Moussa M, Ibraheim R. The role of myeloperoxidase in hepatitis C virus infection and associated liver cirrhosis. Open Tropical Medicine J. 2009; 2: 1-7
  • 79. Mohamadkhani A, Jazii FR, Sayehmiri K, Jafari-Nejad S, Montaser-Kouhsari L, Poustchi H, et al. Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients. Arch Iran Med. 2011; 14(4): 254-8[PubMed]
  • 80. Bin W. Xanthine oxidase and vitamin E in patients with genotype B and C of chronic hepatitis B. Proceed Clin Med. 2007; 9(2)
  • 81. Halliwell B. Oxygen radicals: a commonsense look at their nature and medical importance. Med Biol. 1984; 62(2): 71-7[PubMed]
  • 82. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39(1): 44-84[DOI][PubMed]
  • 83. Fisher-Wellman K, Bell HK, Bloomer RJ. Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxid Med Cell Longev. 2009; 2(1): 43-51[PubMed]
  • 84. Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis. 2005; 5: 95[DOI][PubMed]
  • 85. Moulas A, Noulas A, Makri E, Papadamou G, Bonanou-Tzedaki S, Dalekos G. Total antioxidant status and erythrocyte superoxide dismutase activity in patients with chronic hepatitis B and C. European J Inflam. 2004; 2(2): 77-84
  • 86. Nagoev BS, Ivanova MR. [Role of the antioxidative defense system in the pathogenesis of acute viral hepatitides]. Ter Arkh. 2003; 75(11): 15-7[PubMed]
  • 87. Swietek K, Juszczyk J. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepat. 1997; 4(2): 139-41[PubMed]
  • 88. Kulinskii VI, Leonova ZA, Kolesnichenko LS, Malov IV, Danilov Iu A. [Glutathione system in erythrocytes and plasma in viral hepatitis]. Biomed Khim. 2007; 53(1): 91-8[PubMed]
  • 89. Lin CC, Liu WH, Wang ZH, Yin MC. Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection. Eur J Nutr. 2011; 50(7): 499-506[DOI][PubMed]
  • 90. Chrobot AM, Szaflarska-Szczepanik A, Drewa G. Antioxidant defense in children with chronic viral hepatitis B and C. Med Sci Monit. 2000; 6(4): 713-8[PubMed]
  • 91. Irshad M, Chaudhuri PS, Joshi YK. Superoxide dismutase and total anti-oxidant levels in various forms of liver diseases. Hepatol Res. 2002; 23(3): 178-84[PubMed]
  • 92. Pan WH, Wang CY, Huang SM, Yeh SY, Lin WG, Lin DI, et al. Vitamin A, Vitamin E or beta-carotene status and hepatitis B-related hepatocellular carcinoma. Ann Epidemiol. 1993; 3(3): 217-24[PubMed]
  • 93. Chen YS, Chen YC. Relationship of Plasma Trace Element Levels and Oxidative Stress in Patinet with Hepatopathy Infected with Hepatitis B Virus. Studies Trace Elements Health. 2008; 4(3)
  • 94. Xia C, Liu W, Zeng D, Zhu L, Sun X, Sun X. Effect of hydrogen-rich water on oxidative stress, liver function, and viral load in patients with chronic hepatitis B. Clin Transl Sci. 2013; 6(5): 372-5[DOI][PubMed]
  • 95. Muntean M, Ţăţulescu, D. , Bondor, C. , Aştilean, A. . Antioxidant complementary therapy efficiency evaluation in acute viral hepatitis. Terapeutica, Farmacologie si Toxicologie Clinica. 2008; 12
  • 96. Pár A, Mézes M, Németh P, Jávor T. Effects of cianidanol on the blood lipid peroxide status in patients with chronic hepatitis. Int J Clin Pharmacol Res. 1984; 5(6): 389-97
  • 97. Wang N, Shi X, Guo S, Zhang D, Ren H. A clinical study of N-acetylcysteine treatment in chronic hepatitis B patients]. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi. Chinese J Hepatol. 2008; 16(7): 487-9
  • 98. Shohrati M, Dermanaki F, Babaei F, Alavian SM. Evaluation of the effects of oral N-acetylcysteine and a placebo in paraclinical and oxidative stress parameters of patients with chronic hepatitis B. Hepat Mon. 2010; 10(2): 95-100[PubMed]
  • 99. Shi XF, Guo SH, Wu G, Mao Q, Yu YS, Wang JK, et al. [A multi-center clinical study of N-acetylcysteine on chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2005; 13(1): 20-3[PubMed]
  • 100. Wei F, Liu SK, Liu XY, Li ZJ, Li B, Zhou YL, et al. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B. Eur J Clin Microbiol Infect Dis. 2013; 32(5): 657-69[DOI][PubMed]
  • 101. Andreone P, Fiorino S, Cursaro C, Gramenzi A, Margotti M, Di Giammarino L, et al. Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial. Antiviral Res. 2001; 49(2): 75-81[PubMed]
  • 102. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997; 56(1): 117-24[PubMed]
  • 103. Littler E, Oberg B. Achievements and challenges in antiviral drug discovery. Antivir Chem Chemother. 2005; 16(3): 155-68[PubMed]
  • 104. Armutcu F, Coskun O, Gurel A, Kanter M, Can M, Ucar F, et al. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin Biochem. 2005; 38(6): 540-7[DOI][PubMed]
  • 105. Cicek IE, Cicek E, Kayhan F, Uguz F, Erayman I, Kurban S, et al. The roles of BDNF, S100B, and oxidative stress in interferon-induced depression and the effect of antidepressant treatment in patients with chronic viral hepatitis: a prospective study. J Psychosom Res. 2014; 76(3): 227-32[DOI][PubMed]
  • 106. Bouayed J, Bohn T. Exogenous antioxidants-Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev. 2010; 3(4): 228-37[DOI][PubMed]
  • 107. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004; 37(3): 287-303[DOI][PubMed]
  • 108. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998; 392(6676): 559[DOI][PubMed]
  • 109. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996; 88(21): 1550-9[PubMed]
  • 110. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993; 85(18): 1483-92[PubMed]
  • 111. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol. 2001; 21(22): 7721-30[DOI][PubMed]
  • 112. Kim YS, Seo HW, Jung G. Reactive oxygen species promote heat shock protein 90-mediated HBV capsid assembly. Biochem Biophys Res Commun. 2015; 457(3): 328-33[DOI][PubMed]
  • 113. Alou-El-Makarem MM, Moustafa MM, Fahmy MAA, Abdel-Hamed AM, El-fayomy KN, Darwish MMAS. Evaluation of Carbonylated Proteins in Hepatitis C Virus Patients. Mod Chem appl. 2014; 2(130)
  • 114. Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C. Meta-analysis: antioxidant supplements for liver diseases - the Cochrane Hepato-Biliary Group. Aliment Pharmacol Ther. 2010; 32(3): 356-67[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check